BDMD - CIK 0001982444
The table below shows Baird Medical Investment Holdings Ltd's cash flow statement line items across its last 4 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Operating cash flow | -$1.34M | -$6.31M | -$1.02M | $485.97K |
| Capital expenditure | $42.31K | $2.85M | $2.64M | $5.91M |
| Investing cash flow | -$42.31K | -$2.47M | -$2.65M | -$5.92M |
| Dividends paid | - | - | - | - |
| Stock buybacks | - | - | - | - |
| Financing cash flow | -$1.39M | $10.33M |
Baird Medical Investment Holdings Ltd reported operating cash flow of -$1.34M for fiscal year 2025. That is up 78.7% from -$6.31M in fiscal 2024. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $3.48M |
| $4.41M |